Traditional Chinese medicine effective component compound for preventing and treating fatty liver

Abstract

Disclosed is a traditional Chinese medicine effective component compound for preventing and treating fatty liver. The traditional Chinese medicine effective component compound is characterized in comprising salidroside, gypenosides, curcumin and bighead atractylodes rhizome polysaccharide, wherein the ratio of each component is 4-10 parts of salidroside, 15-20 parts of gypenosides, 3-8 parts of curcumin and 65-75 parts of bighead atractylodes rhizome polysaccharide. Dosage forms of the traditional Chinese medicine effective component compound for preventing and treating fatty liver comprise tablets, capsules, pills, oral liquid or suspensions. The traditional Chinese medicine effective component compound for preventing and treating fatty liver in the invention is safe and effective, has definite active substances, and has more significant effect on preventing and treating fatty liver compared with a component compound containing a single component and Western medicine of polyene phosphatidylcholine capsule.

Description

technical field [0001] The invention relates to a medicine for preventing and treating fatty liver, in particular to a compound prescription of effective components of traditional Chinese medicine for preventing and treating fatty liver. Background technique [0002] 1. Basic overview of existing product technology: [0003] (1) Epidemiology, pathogenesis and current status of Western medicine treatment of non-alcoholic fatty liver [0004] Nonalcoholic fatty liver disease (NAFLD) refers to a clinicopathological syndrome characterized by diffuse bullous steatosis in hepatocytes, which is caused by alcohol and other definite liver damage factors. In recent years, as the pathological manifestation of metabolic diseases in the liver, it has become the target of close clinical monitoring and research, and its related disease spectrum includes simple fatty liver (simple fatty liver, SFL), steatohepatitis (Nonalcoholic steatohepatitis, NASH) , liver cirrhosis and even hepatocell...

AI Technical Summary

Problems solved by technology

[0021] 3. Defects or deficiencies in the process, method, performance, etc. of the existing background technology (necessity and significance of compound research on effective components of traditional Chinese medicine)

[0024] However, there are still relatively few compound researches based on the active ingredients of traditional Chinese medicine, and they have not been involved in many complex disease fields.

Images